Monthly Archives: November 2017

New Parnership with HA Derma & Profhilo

John Bannon Pharma are delighted to announce a new partnership with HA Derma, manufacturers of the Profhilo hyaluronic acid (HA) based product. Profhilo is the first BDDE-free stabilised injectable HA based product for treating skin laxity. With one of the highest concentrations of HA on the market (64mg / 2ml) it is not only boosting and […]

Teoxane RHA1, 2 & 3 Win FDA Approval

Teoxane Laboratories, a global leader in Hyaluronic Acid dermal fillers, are pleased to announce that it has received US Food and Drug Administration (FDA) approval for 3 HA dermal fillers, RHA®2, RHA®3 and RHA®4 for the correction of moderate to severe dynamic facial wrinkles and folds (NLF) in adults aged 22 years or older. Teoxane’s Founder and CEO Mrs […]